Detalles de la búsqueda
1.
Lurasidone and risk of metabolic syndrome: results from short and long-term studies in patients with bipolar depression.
CNS Spectr
; 28(6): 680-687, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36961124
2.
Safety and effectiveness of lurasidone in adolescents with schizophrenia: results of a 2-year, open-label extension study.
CNS Spectr
; 27(1): 118-128, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33077012
3.
C-reactive protein and response to lurasidone treatment in children and adolescents with bipolar I depression: Results from a placebo-controlled trial.
Brain Behav Immun
; 84: 269-274, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31857217
4.
Lurasidone and risk for metabolic syndrome: results from short- and long-term clinical studies in patients with schizophrenia.
CNS Spectr
; : 1-11, 2020 Sep 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32921337
5.
Switching to Lurasidone following 12 months of treatment with Risperidone: results of a 6-month, open-label study.
BMC Psychiatry
; 20(1): 199, 2020 05 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32370778
6.
Association of C-reactive protein and metabolic risk with cognitive effects of lurasidone in patients with schizophrenia.
Compr Psychiatry
; 102: 152195, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32896775
7.
C-reactive protein and response to lurasidone in patients with bipolar depression.
Brain Behav Immun
; 73: 717-724, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30102967
8.
Safety and Effectiveness of Long-Term Treatment with Lurasidone in Older Adults with Bipolar Depression: Post-Hoc Analysis of a 6-Month, Open-Label Study.
Am J Geriatr Psychiatry
; 26(2): 150-159, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29146409
9.
Lurasidone for major depressive disorder with mixed features and anxiety: a post-hoc analysis of a randomized, placebo-controlled study.
CNS Spectr
; 22(2): 236-245, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28357969
10.
Safety and effectiveness of lurasidone in adolescents with schizophrenia: results of a 2-year, open-label extension study -- CORRIGENDUM.
CNS Spectr
; 27(1): 129, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33998439
11.
Lurasidone for major depressive disorder with mixed features and irritability: a post-hoc analysis.
CNS Spectr
; 22(2): 228-235, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28300012
12.
Long-term safety and effectiveness of lurasidone in schizophrenia: a 22-month, open-label extension study.
CNS Spectr
; 21(5): 393-402, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27048911
13.
Long-term health-related quality of life improvements among patients treated with lurasidone: results from the open-label extension of a switch trial in schizophrenia.
BMC Psychiatry
; 16: 176, 2016 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27245981
14.
Effects on health-related quality of life in patients treated with lurasidone for bipolar depression: results from two placebo controlled bipolar depression trials.
BMC Psychiatry
; 16: 157, 2016 05 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-27215976
15.
Lurasidone for the treatment of depressive symptoms in schizophrenia: analysis of 4 pooled, 6-week, placebo-controlled studies.
CNS Spectr
; 20(2): 140-7, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24955752
16.
Daytime sleepiness associated with lurasidone and quetiapine XR: results from a randomized double-blind, placebo-controlled trial in patients with schizophrenia.
CNS Spectr
; 19(2): 197-205, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24330860
17.
Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia.
BMC Psychiatry
; 14: 53, 2014 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-24559217
18.
Sleep Disturbance, Irritability, and Response to Lurasidone Treatment in Children and Adolescents with Bipolar Depression.
Curr Neuropharmacol
; 21(6): 1393-1404, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36173066
19.
The Effect of Lurasidone on Anxiety Symptoms in Patients With Bipolar Depression: A Post Hoc Analysis.
J Clin Psychiatry
; 84(4)2023 06 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37339360
20.
Long-term safety and effectiveness of open-label lurasidone in antipsychotic-Naïve versus previously treated adolescents with Schizophrenia: A post-hoc analysis.
Schizophr Res
; 240: 205-213, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35032906